Liu, H., Ai, Y., Wang, Z., Yuan, D., Zhan, P., Yao, Y. (2025). Camrelizumab combined with 2 cycles of chemotherapy as first-line treatment for advanced non-small cell lung cancer (NSCLC): A two-arm, single-center, phase 2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8548